Montag, 09. September 2024, 8:00-9:30 Uhr
Session: »Mechanistic studies in respiratory infection«
»Acetate inhibits Pseudomonas aeruginosa growth and reduces inflammatory responses to infection in primary human lung tissue ex vivo«
Rednerin: Franziska Dahlmann
Montag, 09. September 2024, 12:30-14:00 Uhr
Session: »Novel insights in the pathogenesis of pulmonary fibrosis«
»Understanding the Dynamics of Pro-Fibrotic Biomarkers in PCLS: Implications for Pre-clinical Studies«
Rednerin: Lena Willmer
Dienstag, 10. September 2024, 12:30-14:00 Uhr
Session: »Developing and assessing treatments for respiratory infection«
»Antiviral RNAi inhalation inhibits human parainfluenza infection ex vivo and in vivo«
Redner: Philippe Vollmer Barbosa
»Advanced in vitro and ex vivo models provide a suitable platform for the evaluation of antiviral small molecules against human parainfluenza virus 3«
Redner: Fabian Röpken
Dienstag, 10. September 2024, 8:00-9:30 Uhr
Session: »New aspects of lung function, inhalers and clinical management for asthma and COPD«
»A novel macrolide, EP395, in a LPS challenge in healthy volunteers«
Redner: Jens Hohlfeld